143 related articles for article (PubMed ID: 35022636)
21. A novel HSP90 inhibitor delays castrate-resistant prostate cancer without altering serum PSA levels and inhibits osteoclastogenesis.
Lamoureux F; Thomas C; Yin MJ; Kuruma H; Fazli L; Gleave ME; Zoubeidi A
Clin Cancer Res; 2011 Apr; 17(8):2301-13. PubMed ID: 21349995
[TBL] [Abstract][Full Text] [Related]
22. Polylactide nanoparticles encapsulating indocyanine green for photothermal therapy of prostate cancer cells.
Güney Akkurt M; Gülsoy M
Photodiagnosis Photodyn Ther; 2022 Mar; 37():102693. PubMed ID: 34921985
[TBL] [Abstract][Full Text] [Related]
23. Hsp90 inhibitor 17-AAG inhibits progression of LuCaP35 xenograft prostate tumors to castration resistance.
O'Malley KJ; Langmann G; Ai J; Ramos-Garcia R; Vessella RL; Wang Z
Prostate; 2012 Jul; 72(10):1117-23. PubMed ID: 22161776
[TBL] [Abstract][Full Text] [Related]
24. 17-Allylamino-17-demethoxygeldanamycin induces the degradation of androgen receptor and HER-2/neu and inhibits the growth of prostate cancer xenografts.
Solit DB; Zheng FF; Drobnjak M; Münster PN; Higgins B; Verbel D; Heller G; Tong W; Cordon-Cardo C; Agus DB; Scher HI; Rosen N
Clin Cancer Res; 2002 May; 8(5):986-93. PubMed ID: 12006510
[TBL] [Abstract][Full Text] [Related]
25. Silencing of survivin gene by small interfering RNAs produces supra-additive growth suppression in combination with 17-allylamino-17-demethoxygeldanamycin in human prostate cancer cells.
Paduano F; Villa R; Pennati M; Folini M; Binda M; Daidone MG; Zaffaroni N
Mol Cancer Ther; 2006 Jan; 5(1):179-86. PubMed ID: 16432177
[TBL] [Abstract][Full Text] [Related]
26. Effect of the hsp90 inhibitor geldanamycin on androgen response of prostate cancer under hypoxic conditions.
Suzuki Y; Kondo Y; Hara S; Kimata R; Nishimura T
Int J Urol; 2010 Mar; 17(3):281-5. PubMed ID: 20409220
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin's lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular signal-regulated kinase, and induces cell cycle arrest and cell death.
Georgakis GV; Li Y; Rassidakis GZ; Martinez-Valdez H; Medeiros LJ; Younes A
Clin Cancer Res; 2006 Jan; 12(2):584-90. PubMed ID: 16428504
[TBL] [Abstract][Full Text] [Related]
28. Calcium-carbonate packaging magnetic polydopamine nanoparticles loaded with indocyanine green for near-infrared induced photothermal/photodynamic therapy.
Xue P; Hou M; Sun L; Li Q; Zhang L; Xu Z; Kang Y
Acta Biomater; 2018 Nov; 81():242-255. PubMed ID: 30267884
[TBL] [Abstract][Full Text] [Related]
29. Clusterin inhibition using OGX-011 synergistically enhances Hsp90 inhibitor activity by suppressing the heat shock response in castrate-resistant prostate cancer.
Lamoureux F; Thomas C; Yin MJ; Kuruma H; Beraldi E; Fazli L; Zoubeidi A; Gleave ME
Cancer Res; 2011 Sep; 71(17):5838-49. PubMed ID: 21737488
[TBL] [Abstract][Full Text] [Related]
30. Synchronous delivery of oxygen and photosensitizer for alleviation of hypoxia tumor microenvironment and dramatically enhanced photodynamic therapy.
Guo X; Qu J; Zhu C; Li W; Luo L; Yang J; Yin X; Li Q; Du Y; Chen D; Qiu Y; Lou Y; You J
Drug Deliv; 2018 Nov; 25(1):585-599. PubMed ID: 29461122
[TBL] [Abstract][Full Text] [Related]
31. Image-guided photo-therapeutic nanoporphyrin synergized HSP90 inhibitor in patient-derived xenograft bladder cancer model.
Long Q; Lin TY; Huang Y; Li X; Ma AH; Zhang H; Carney R; Airhart S; Lam KS; deVere White RW; Pan CX; Li Y
Nanomedicine; 2018 Apr; 14(3):789-799. PubMed ID: 29317342
[TBL] [Abstract][Full Text] [Related]
32. Gold-caged copolymer nanoparticles as multimodal synergistic photodynamic/photothermal/chemotherapy platform against lethality androgen-resistant prostate cancer.
Wang Q; Zhang X; Sun Y; Wang L; Ding L; Zhu WH; Di W; Duan YR
Biomaterials; 2019 Aug; 212():73-86. PubMed ID: 31108274
[TBL] [Abstract][Full Text] [Related]
33. Photodynamic therapy using pheophorbide and 670nm LEDs exhibits anti-cancer effects in-vitro in androgen dependent prostate cancer.
Gheewala T; Skwor T; Munirathinam G
Photodiagnosis Photodyn Ther; 2018 Mar; 21():130-137. PubMed ID: 29102652
[TBL] [Abstract][Full Text] [Related]
34. Near infrared light triggered ternary synergistic cancer therapy via L-arginine-loaded nanovesicles with modification of PEGylated indocyanine green.
Wang K; Jiang L; Qiu L
Acta Biomater; 2022 Mar; 140():506-517. PubMed ID: 34902616
[TBL] [Abstract][Full Text] [Related]
35. Abrogation of heat shock protein 70 induction as a strategy to increase antileukemia activity of heat shock protein 90 inhibitor 17-allylamino-demethoxy geldanamycin.
Guo F; Rocha K; Bali P; Pranpat M; Fiskus W; Boyapalle S; Kumaraswamy S; Balasis M; Greedy B; Armitage ES; Lawrence N; Bhalla K
Cancer Res; 2005 Nov; 65(22):10536-44. PubMed ID: 16288046
[TBL] [Abstract][Full Text] [Related]
36. Hyperthermia and Controllable Free Radical Coenhanced Synergistic Therapy in Hypoxia Enabled by Near-Infrared-II Light Irradiation.
Yang J; Xie R; Feng L; Liu B; Lv R; Li C; Gai S; He F; Yang P; Lin J
ACS Nano; 2019 Nov; 13(11):13144-13160. PubMed ID: 31609581
[TBL] [Abstract][Full Text] [Related]
37. Delivery of MutT homolog 1 inhibitor by functionalized graphene oxide nanoparticles for enhanced chemo-photodynamic therapy triggers cell death in osteosarcoma.
Huang X; Chen J; Wu W; Yang W; Zhong B; Qing X; Shao Z
Acta Biomater; 2020 Jun; 109():229-243. PubMed ID: 32294550
[TBL] [Abstract][Full Text] [Related]
38. Potent activity of the Hsp90 inhibitor ganetespib in prostate cancer cells irrespective of androgen receptor status or variant receptor expression.
He S; Zhang C; Shafi AA; Sequeira M; Acquaviva J; Friedland JC; Sang J; Smith DL; Weigel NL; Wada Y; Proia DA
Int J Oncol; 2013 Jan; 42(1):35-43. PubMed ID: 23152004
[TBL] [Abstract][Full Text] [Related]
39. A near infrared light-triggered human serum albumin drug delivery system with coordination bonding of indocyanine green and cisplatin for targeting photochemistry therapy against oral squamous cell cancer.
Wang Y; Xie D; Pan J; Xia C; Fan L; Pu Y; Zhang Q; Ni YH; Wang J; Hu Q
Biomater Sci; 2019 Dec; 7(12):5270-5282. PubMed ID: 31603446
[TBL] [Abstract][Full Text] [Related]
40. Intelligent Tumor Microenvironment-Activated Multifunctional Nanoplatform Coupled with Turn-on and Always-on Fluorescence Probes for Imaging-Guided Cancer Treatment.
Sun Y; Wang Y; Liu Y; Weng B; Yang H; Xiang Z; Ran J; Wang H; Yang C
ACS Appl Mater Interfaces; 2021 Nov; 13(45):53646-53658. PubMed ID: 34748304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
